Dietary Intervention and BRCA Penetrance
Lifestyle and the Penetrance of BRCA Mutation
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A NA clinical study on BRCA1 Mutation and BRCA2 Mutation, this trial is completed. The trial is conducted by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano and has accumulated 8 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2021 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2021 — Nov 2021 [monthly]
Unknown Status NA
▶ Show 3 earlier versions
-
Mar 2019 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Mar 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Istituto Oncologico di Bari
For direct contact, visit the study record on ClinicalTrials.gov .